Johnson & Johnson
NYSE: JNJ
$164.11
-$0.71 (-0.4%)
Closing Price on September 20, 2024
JNJ Articles
These five incredible blue chip leaders have raised the dividends they pay to shareholders for almost 60 years. The stocks look like great ideas now for worried investors looking for some growth and...
Published:
Here's what to expect when five major companies report earnings next Monday afternoon and Tuesday morning.
Published:
Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology and Vertex Pharmaceuticals.
Published:
Three Dow Jones industrial average components are reporting June-quarter results before markets open Wednesday.
Published:
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Dollar General, Johnson & Johnson, HP and Teladoc.
Published:
Earnings season hits its stride next week and here are previews of four companies reporting March quarter results early Tuesday.
Published:
Johnson & Johnson officially enters the fight against COVID-19 as its single-shot vaccine was approved over the weekend. It plans to deliver 100 million single-shot vaccines during the first half of...
Published:
These five BofA Securities high-quality stock picks have good prospects for the rest of 2021 and should continue to be accompanied by dependable dividends. They may be an alternative for conservative...
Published:
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Apple, Boeing, Microsoft and Verizon.
Published:
While positive earnings could continue to drive the major indexes higher in 2021, a very overbought and fully valued market could offer some painful January indigestion. These five stocks look like...
Published:
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Published:
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Published:
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Published:
Johnson & Johnson released better than expected quarterly results before the markets opened on Tuesday, but it also announced a pause in its late-stage coronavirus vaccine trial.
Published: